[Form 4] Hippo Holdings Inc. Insider Trading Activity

Rhea-AI Filing Summary

Torben Ostergaard, reporting person and officer at Hippo Holdings Inc. (HIPO), reported a sale of 2,016 shares of Hippo common stock on 08/15/2025 at a price of $30.91 per share. After the transaction he beneficially owned 62,333 shares, which the filing notes include 56,121 RSUs. The Form 4 was signed by an attorney-in-fact on 08/18/2025. The filing provides only the single non-derivative sale and the post-transaction beneficial ownership amount.

Positive

• None.

Negative

• Officer disposed of 2,016 shares of Hippo common stock on 08/15/2025 at $30.91 per share
• Post-transaction ownership remains concentrated in RSUs (56,121 RSUs included in 62,333 total), which may limit transferable share liquidity

Insights

Financial Analyst

TL;DR: Routine insider stock sale of 2,016 shares; post-sale holdings remain concentrated in RSUs.

The transaction is a straightforward non-derivative sale of 2,016 Hippo shares at $30.91 on 08/15/2025. Post-transaction beneficial ownership is 62,333 shares with 56,121 identified as RSUs, indicating most holdings are restricted equity rather than open-market stock. There is no additional context in the filing about purpose, 10b5-1 plan, or whether proceeds were used for diversification, tax, or other reasons, so the sale should be viewed as a discrete insider disposition without further disclosed material implications.

Corporate Governance Expert

TL;DR: Standard Form 4 disclosure for an officer-initiated sale; record shows substantial RSU balance.

The filing complies with Section 16 reporting: it discloses an officer sale and quantifies remaining beneficial ownership including a large RSU component (56,121 RSUs). The presence of significant RSUs suggests alignment with company compensation practices. The form does not state if the sale was under a pre-arranged plan or provide timing rationale, limiting governance-readers to a compliance-level assessment rather than governance-concern evidence.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ostergaard Torben

(Last) (First) (Middle)

C/O HIPPO HOLDINGS INC., 1 ALMADEN BLVD

SUITE 400

(Street)

SAN JOSE CA 95113

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hippo Holdings Inc. [ HIPO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO Spinnaker

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		F		2,016	D	$30.91	62,333(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 56,121 RSUs.

Remarks:

	/s /Guy Zeltser, Attorney-in-Fact for Torben Ostergaard	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Torben Ostergaard report in the HIPO Form 4?

The filing reports a sale of 2,016 shares on 08/15/2025 at $30.91, leaving 62,333 shares beneficially owned (including 56,121 RSUs).

How many shares does the reporting person own after the transaction?

After the reported sale the filing shows 62,333 shares beneficially owned, which the filer explains include 56,121 RSUs.

What type of transaction was disclosed on the Form 4 for HIPO?

The Form 4 discloses a non-derivative sale (transaction code F) of common stock executed on 08/15/2025.

Does the Form 4 state whether the sale was part of a 10b5-1 plan?

The filing does not state that the transaction was made pursuant to a 10b5-1 plan or otherwise provide a plan reference.

Who signed the Form 4 filing for Torben Ostergaard?

The Form 4 was signed by Guy Zeltser, Attorney-in-Fact for Torben Ostergaard on 08/18/2025.